Vivimusta 25 MG/ML Injectable Solution

RxCUI
2622914
RxNorm name
Vivimusta 25 MG/ML Injectable Solution
Display name
Vivimusta 25 MG/ML Injectable Solution
Full name
Vivimusta 25 MG/ML Injectable Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VIVIMUSTABENDAMUSTINE HYDROCHLORIDEAzurity Pharmaceuticals, Inc.4df6548f-c4ad-4eb2-a54f-19766a3d90ca2025-04-03Warnings, Adverse reactionsExact identifier
rxcui: 2622914
VIVIMUSTABENDAMUSTINE HYDROCHLORIDESlayback Pharma LLCcbcc6eb7-aa62-4599-af49-05203fedb4bb2024-02-27Warnings, Adverse reactionsExact identifier
rxcui: 2622914

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cbcc6eb7-aa62-4599-af49-05203fedb4bbVIVIMUSTA 25 MG/ML Injectable Solution [PSN] · bendamustine hydrochloride 25 MG/ML Injectable Solution [Vivimusta] [SBD] · Vivimusta 25 MG/ML Injectable Solution [SY]322These highlights do not include all the information needed to use VIVIMUSTA safely and effectively. See full prescribing information for VIVIMUSTA. VIVIMUSTA® (bendamustine hydrochloride injection), for intravenous use. Initial U.S. Approval: 200820240227
4df6548f-c4ad-4eb2-a54f-19766a3d90caVIVIMUSTA 25 MG/ML Injectable Solution [PSN] · bendamustine hydrochloride 25 MG/ML Injectable Solution [Vivimusta] [SBD] · Vivimusta 25 MG/ML Injectable Solution [SY]32These highlights do not include all the information needed to use VIVIMUSTA safely and effectively. See full prescribing information for VIVIMUSTA. VIVIMUSTA® (bendamustine hydrochloride injection), for intravenous use. Initial U.S. Approval: 200820250403